Alternative Access for Transcatheter Aortic Valve Implantation: Current Evidence and Future Directions
Author(s) -
J J Coughlan,
Thomas J. Kiernan,
Samer Arnous
Publication year - 2019
Publication title -
vascular and endovascular review
Language(s) - English
Resource type - Journals
eISSN - 2516-3302
pISSN - 2516-3299
DOI - 10.15420/ver.2019.4.2
Subject(s) - medicine , stenosis , vascular access , aortic valve stenosis , cardiology , aortic valve , clinical trial , surgery , aortic valve replacement , hemodialysis
© R A D C L I F F E C A R D I O L O G Y 2 0 1 9 Access at: www.VERjournal.com Transcatheter aortic valve implantation (TAVI) has emerged as the treatment of choice for patients with severe aortic stenosis (AS) deemed to be at high risk for surgical aortic valve replacement. Recent trials have suggested equipoise with regard to outcomes in patients with an intermediate risk, and clinical trials are underway in low-risk patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom